Rheumatic Disorders Drug Market, Global Outlook and Forecast 2022-2028

March 2022 | 65 pages | ID: R1639B554769EN
Market Monitor Global

Abstracts

Treatment of drugs for regulating rheumatic diseases

This report contains market size and forecasts of Rheumatic Disorders Drug in Global, including the following market information:

Global Rheumatic Disorders Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Rheumatic Disorders Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Acting on Tumor Necrosis Factor-Alpha Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Rheumatic Disorders Drug include AbbVie, Amgen, Johnson & Johnson, Novartis, Pfizer, Roche, Eli Lilly and Bristol-Myers Squibb, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Rheumatic Disorders Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Rheumatic Disorders Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Rheumatic Disorders Drug Market Segment Percentages, by Type, 2021 (%)

• Acting on Tumor Necrosis Factor-Alpha
• Acting on Interleukins and Interleukin Receptors
• Acting on Protein Kinases
• Acting on Cell Surface Antigens
• Acting on Hormones and Hormone Receptors
• Others

Global Rheumatic Disorders Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Rheumatic Disorders Drug Market Segment Percentages, by Application, 2021 (%)

• Rheumatoid Arthritis
• Osteoarthritis
• Osteoporosis
• Systemic Lupus Erythematosus
• Psoriatic Arthritis
• Others

Global Rheumatic Disorders Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Rheumatic Disorders Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Rheumatic Disorders Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Rheumatic Disorders Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• AbbVie
• Amgen
• Johnson & Johnson
• Novartis
• Pfizer
• Roche
• Eli Lilly
• Bristol-Myers Squibb

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Rheumatic Disorders Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Rheumatic Disorders Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL RHEUMATIC DISORDERS DRUG OVERALL MARKET SIZE

2.1 Global Rheumatic Disorders Drug Market Size: 2021 VS 2028
2.2 Global Rheumatic Disorders Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Rheumatic Disorders Drug Players in Global Market
3.2 Top Global Rheumatic Disorders Drug Companies Ranked by Revenue
3.3 Global Rheumatic Disorders Drug Revenue by Companies
3.4 Top 3 and Top 5 Rheumatic Disorders Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Rheumatic Disorders Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Rheumatic Disorders Drug Players in Global Market
  3.6.1 List of Global Tier 1 Rheumatic Disorders Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Rheumatic Disorders Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Rheumatic Disorders Drug Market Size Markets, 2021 & 2028
  4.1.2 Acting on Tumor Necrosis Factor-Alpha
  4.1.3 Acting on Interleukins and Interleukin Receptors
  4.1.4 Acting on Protein Kinases
  4.1.5 Acting on Cell Surface Antigens
  4.1.6 Acting on Hormones and Hormone Receptors
  4.1.7 Others
4.2 By Type - Global Rheumatic Disorders Drug Revenue & Forecasts
  4.2.1 By Type - Global Rheumatic Disorders Drug Revenue, 2017-2022
  4.2.2 By Type - Global Rheumatic Disorders Drug Revenue, 2023-2028
  4.2.3 By Type - Global Rheumatic Disorders Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Rheumatic Disorders Drug Market Size, 2021 & 2028
  5.1.2 Rheumatoid Arthritis
  5.1.3 Osteoarthritis
  5.1.4 Osteoporosis
  5.1.5 Systemic Lupus Erythematosus
  5.1.6 Psoriatic Arthritis
  5.1.7 Others
5.2 By Application - Global Rheumatic Disorders Drug Revenue & Forecasts
  5.2.1 By Application - Global Rheumatic Disorders Drug Revenue, 2017-2022
  5.2.2 By Application - Global Rheumatic Disorders Drug Revenue, 2023-2028
  5.2.3 By Application - Global Rheumatic Disorders Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Rheumatic Disorders Drug Market Size, 2021 & 2028
6.2 By Region - Global Rheumatic Disorders Drug Revenue & Forecasts
  6.2.1 By Region - Global Rheumatic Disorders Drug Revenue, 2017-2022
  6.2.2 By Region - Global Rheumatic Disorders Drug Revenue, 2023-2028
  6.2.3 By Region - Global Rheumatic Disorders Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Rheumatic Disorders Drug Revenue, 2017-2028
  6.3.2 US Rheumatic Disorders Drug Market Size, 2017-2028
  6.3.3 Canada Rheumatic Disorders Drug Market Size, 2017-2028
  6.3.4 Mexico Rheumatic Disorders Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Rheumatic Disorders Drug Revenue, 2017-2028
  6.4.2 Germany Rheumatic Disorders Drug Market Size, 2017-2028
  6.4.3 France Rheumatic Disorders Drug Market Size, 2017-2028
  6.4.4 U.K. Rheumatic Disorders Drug Market Size, 2017-2028
  6.4.5 Italy Rheumatic Disorders Drug Market Size, 2017-2028
  6.4.6 Russia Rheumatic Disorders Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Rheumatic Disorders Drug Market Size, 2017-2028
  6.4.8 Benelux Rheumatic Disorders Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Rheumatic Disorders Drug Revenue, 2017-2028
  6.5.2 China Rheumatic Disorders Drug Market Size, 2017-2028
  6.5.3 Japan Rheumatic Disorders Drug Market Size, 2017-2028
  6.5.4 South Korea Rheumatic Disorders Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Rheumatic Disorders Drug Market Size, 2017-2028
  6.5.6 India Rheumatic Disorders Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Rheumatic Disorders Drug Revenue, 2017-2028
  6.6.2 Brazil Rheumatic Disorders Drug Market Size, 2017-2028
  6.6.3 Argentina Rheumatic Disorders Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Rheumatic Disorders Drug Revenue, 2017-2028
  6.7.2 Turkey Rheumatic Disorders Drug Market Size, 2017-2028
  6.7.3 Israel Rheumatic Disorders Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Rheumatic Disorders Drug Market Size, 2017-2028
  6.7.5 UAE Rheumatic Disorders Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 AbbVie
  7.1.1 AbbVie Corporate Summary
  7.1.2 AbbVie Business Overview
  7.1.3 AbbVie Rheumatic Disorders Drug Major Product Offerings
  7.1.4 AbbVie Rheumatic Disorders Drug Revenue in Global Market (2017-2022)
  7.1.5 AbbVie Key News
7.2 Amgen
  7.2.1 Amgen Corporate Summary
  7.2.2 Amgen Business Overview
  7.2.3 Amgen Rheumatic Disorders Drug Major Product Offerings
  7.2.4 Amgen Rheumatic Disorders Drug Revenue in Global Market (2017-2022)
  7.2.5 Amgen Key News
7.3 Johnson & Johnson
  7.3.1 Johnson & Johnson Corporate Summary
  7.3.2 Johnson & Johnson Business Overview
  7.3.3 Johnson & Johnson Rheumatic Disorders Drug Major Product Offerings
  7.3.4 Johnson & Johnson Rheumatic Disorders Drug Revenue in Global Market (2017-2022)
  7.3.5 Johnson & Johnson Key News
7.4 Novartis
  7.4.1 Novartis Corporate Summary
  7.4.2 Novartis Business Overview
  7.4.3 Novartis Rheumatic Disorders Drug Major Product Offerings
  7.4.4 Novartis Rheumatic Disorders Drug Revenue in Global Market (2017-2022)
  7.4.5 Novartis Key News
7.5 Pfizer
  7.5.1 Pfizer Corporate Summary
  7.5.2 Pfizer Business Overview
  7.5.3 Pfizer Rheumatic Disorders Drug Major Product Offerings
  7.5.4 Pfizer Rheumatic Disorders Drug Revenue in Global Market (2017-2022)
  7.5.5 Pfizer Key News
7.6 Roche
  7.6.1 Roche Corporate Summary
  7.6.2 Roche Business Overview
  7.6.3 Roche Rheumatic Disorders Drug Major Product Offerings
  7.6.4 Roche Rheumatic Disorders Drug Revenue in Global Market (2017-2022)
  7.6.5 Roche Key News
7.7 Eli Lilly
  7.7.1 Eli Lilly Corporate Summary
  7.7.2 Eli Lilly Business Overview
  7.7.3 Eli Lilly Rheumatic Disorders Drug Major Product Offerings
  7.7.4 Eli Lilly Rheumatic Disorders Drug Revenue in Global Market (2017-2022)
  7.7.5 Eli Lilly Key News
7.8 Bristol-Myers Squibb
  7.8.1 Bristol-Myers Squibb Corporate Summary
  7.8.2 Bristol-Myers Squibb Business Overview
  7.8.3 Bristol-Myers Squibb Rheumatic Disorders Drug Major Product Offerings
  7.8.4 Bristol-Myers Squibb Rheumatic Disorders Drug Revenue in Global Market (2017-2022)
  7.8.5 Bristol-Myers Squibb Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Rheumatic Disorders Drug Market Opportunities & Trends in Global Market
Table 2. Rheumatic Disorders Drug Market Drivers in Global Market
Table 3. Rheumatic Disorders Drug Market Restraints in Global Market
Table 4. Key Players of Rheumatic Disorders Drug in Global Market
Table 5. Top Rheumatic Disorders Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Rheumatic Disorders Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Rheumatic Disorders Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Rheumatic Disorders Drug Product Type
Table 9. List of Global Tier 1 Rheumatic Disorders Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Rheumatic Disorders Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Rheumatic Disorders Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Rheumatic Disorders Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Rheumatic Disorders Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Rheumatic Disorders Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Rheumatic Disorders Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Rheumatic Disorders Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Rheumatic Disorders Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Rheumatic Disorders Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Rheumatic Disorders Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Rheumatic Disorders Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Rheumatic Disorders Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Rheumatic Disorders Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Rheumatic Disorders Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Rheumatic Disorders Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Rheumatic Disorders Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Rheumatic Disorders Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Rheumatic Disorders Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Rheumatic Disorders Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Rheumatic Disorders Drug Revenue, (US$, Mn), 2023-2028
Table 30. AbbVie Corporate Summary
Table 31. AbbVie Rheumatic Disorders Drug Product Offerings
Table 32. AbbVie Rheumatic Disorders Drug Revenue (US$, Mn), (2017-2022)
Table 33. Amgen Corporate Summary
Table 34. Amgen Rheumatic Disorders Drug Product Offerings
Table 35. Amgen Rheumatic Disorders Drug Revenue (US$, Mn), (2017-2022)
Table 36. Johnson & Johnson Corporate Summary
Table 37. Johnson & Johnson Rheumatic Disorders Drug Product Offerings
Table 38. Johnson & Johnson Rheumatic Disorders Drug Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis Rheumatic Disorders Drug Product Offerings
Table 41. Novartis Rheumatic Disorders Drug Revenue (US$, Mn), (2017-2022)
Table 42. Pfizer Corporate Summary
Table 43. Pfizer Rheumatic Disorders Drug Product Offerings
Table 44. Pfizer Rheumatic Disorders Drug Revenue (US$, Mn), (2017-2022)
Table 45. Roche Corporate Summary
Table 46. Roche Rheumatic Disorders Drug Product Offerings
Table 47. Roche Rheumatic Disorders Drug Revenue (US$, Mn), (2017-2022)
Table 48. Eli Lilly Corporate Summary
Table 49. Eli Lilly Rheumatic Disorders Drug Product Offerings
Table 50. Eli Lilly Rheumatic Disorders Drug Revenue (US$, Mn), (2017-2022)
Table 51. Bristol-Myers Squibb Corporate Summary
Table 52. Bristol-Myers Squibb Rheumatic Disorders Drug Product Offerings
Table 53. Bristol-Myers Squibb Rheumatic Disorders Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Rheumatic Disorders Drug Segment by Type in 2021
Figure 2. Rheumatic Disorders Drug Segment by Application in 2021
Figure 3. Global Rheumatic Disorders Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Rheumatic Disorders Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Rheumatic Disorders Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Rheumatic Disorders Drug Revenue in 2021
Figure 8. By Type - Global Rheumatic Disorders Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Rheumatic Disorders Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Rheumatic Disorders Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Rheumatic Disorders Drug Revenue Market Share, 2017-2028
Figure 12. US Rheumatic Disorders Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Rheumatic Disorders Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Rheumatic Disorders Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Rheumatic Disorders Drug Revenue Market Share, 2017-2028
Figure 16. Germany Rheumatic Disorders Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Rheumatic Disorders Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Rheumatic Disorders Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Rheumatic Disorders Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Rheumatic Disorders Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Rheumatic Disorders Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Rheumatic Disorders Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Rheumatic Disorders Drug Revenue Market Share, 2017-2028
Figure 24. China Rheumatic Disorders Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Rheumatic Disorders Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Rheumatic Disorders Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Rheumatic Disorders Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Rheumatic Disorders Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Rheumatic Disorders Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Rheumatic Disorders Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Rheumatic Disorders Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Rheumatic Disorders Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Rheumatic Disorders Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Rheumatic Disorders Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Rheumatic Disorders Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Rheumatic Disorders Drug Revenue, (US$, Mn), 2017-2028
Figure 37. AbbVie Rheumatic Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Amgen Rheumatic Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Johnson & Johnson Rheumatic Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis Rheumatic Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Pfizer Rheumatic Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Roche Rheumatic Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Eli Lilly Rheumatic Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Bristol-Myers Squibb Rheumatic Disorders Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)